Autres langues Mega Lifesciences Thailand S.E.

Actions

MEGA-R

TH4984010R19

Produits pharmaceutiques

Cours en clôture Thailand S.E. 18/08/2026			Varia. 5j.	Varia. 1 janv.
37,50 ^THB	0,00%		-3,23%	+11,94%

13/08	Mega Lifesciences Public Company Limited publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
16/05	Transcript : Mega Lifesciences Public Company Limited, Q1 2026 Earnings Call, May 14, 2026

Autres langues

13/08	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/05	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
03/04	Mega Lifesciences Public Company Limited Approves Final Cash Dividend for the Year Ended 31 December 2025, Payable on 24 April 2026
03/04	Mega Lifesciences Public Company Limited Appoints Plakorn Wanglee as an Independent Director
24/02	Mega Lifesciences Public Company Limited Proposes Final Cash Dividend for the Year Ended 31 December 2025, Payable on 24 April 2026
24/02	Mega Lifesciences Public Company Limited Approved Board and Committee Changes
24/02	Mega Lifesciences logs FY overall operating revenue 14,147 mln baht
24/02	Mega Lifesciences Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
13/11	Mega Lifesciences posts qtrly reported net profit 494 million baht
13/11	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
14/08/25	Mega Lifesciences posts qtrly operating revenue 3,953.8 million baht
14/08/25	Mega Lifesciences Public Company Limited Announces Interim Cash Dividend for the Period from 01 January 2025 to 30 June 2025, Payable on September 12, 2025
14/05/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025
04/04/25	Mega Lifesciences Public Company Limited Approves Final Dividend from the Operation Results for the Fiscal Year Ended December 31, 2024, Payable on April 24, 2025
24/02/25	Mega Lifesciences Public Company Limited Proposes Cash Dividend for the Year Ended 31 December, 2024, Payable on 24 April, 2025
24/02/25	Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024
12/11/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
13/08/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
13/08/24	Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from 01-Jan-2024 to 30-Jun-2024, Payable on September 10, 2024
13/05/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
22/02/24	Mega Lifesciences Public Company Limited Proposes Dividend for the Year Ended December 31, 2023, Payable on April 22, 2024
22/02/24	Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
13/11/23	Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11/08/23	Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2023to June 30, 2023, Payable on September 8, 2023